Tag:
Dicerna Pharmaceuticals
Latest Headlines
Latest Headlines
Dicerna gets another $4M for RNAi work
Watertown, MA-based Dicerna Pharmaceuticals says it's added another $4 million in financing, bringing the developer's total haul to $29 million. GlaxoSmithKline's venture arm SR One joined the
Dicerna gets $25M validation of RNA delivery tech
We previously discussed the great promises and challenges long associated with RNAi technology. It made a big splash when it was discovered a dozen years ago because of its potential to "silence"
Dicerna bags $25M Series B for next-gen RNAi work
Dicerna Pharmaceuticals has landed a $25 million Series B to fuel its work on a new and improved slate of gene-silencing therapies. Still in the preclinical stage, the Watertown, MA-based developer
Dicerna lands $124M RNAi development pact
Start-up Dicerna Pharmaceuticals, which bills itself as a second-generation RNAi developer, has found its first sizeable partner in Japan. Kyowa Hakko Kirin says it will hand over a $4 million
LSO rounds up $40M in third venture round
Bellevue, WA-based Light Sciences Oncology has garnered $40.1 million in new venture funds to advance its work on light infusion therapies. The developer has raised $97 million in two earlier rounds,
